@article{article_392017, title={B Cell Targeted Terapies in Rheumatoid Arthritis}, journal={Journal of Uludağ University Medical Faculty}, volume={37}, pages={161–164}, year={2011}, url={https://izlik.org/JA39BF64TG}, author={Dalkılıç, Ediz and Alkış, Nihan}, keywords={Romatoid Artrit. Rituksimab. Ocralizumab. Ofatumumab. B lenfosit}, abstract={Rheumatoid arthritis (RA), is a chronic, systemic, inflammatory disease with usually symetric polyarticular involvement. In term of inade-quate therapies it leads to substantial morbidity and mortality. Last ten years, there are great developments in the etiopathogenesis and treat-ment of RA. Biologic agents starting with tumor necrosis factor alpha inhibitors and in recent years, B cell targeted therapies opened a new era in the treatment of patients with RA.}, number={3}